|
|
 |
|
Viewing report
|
|
|
|
World Insulin Management Systems Market
Frost & Sullivan, March 2011, Pages: 42
This research service looks at the global insulin management systems market, covering all countries. The segments covered are diabetes drugs and diabetes devices markets. The diabetes drugs market is divided into insulin and non-insulin markets. The diabetes devices market consists of insulin delivery devices and monitoring devices segment. A review of products has been provided for all components of the insulin management system. Total market analyses include market drivers and restraints, market share analysis, revenue forecasts and product profiles
Research Overview
This Frost & Sullivan research service titled World Insulin Management Systems Market provides market size and trends and revenue forecasts. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: diabetes therapeutics and diagnostics markets.
Market Overview
Demand for Diabetes Solutions Surges and Population of Diabetics Soars
The increasing prevalence of diabetes, including type-I diabetes, is ensuring rapid growth for the insulin delivery devices market. Insulin management systems are set to experience accelerated market expansion, notwithstanding the higher costs associated with the use of insulin pumps, when compared to alternate insulin delivery devices. Advances in continuous glucose monitoring (CGM) technology and the integration of CGM into insulin pumps has launched a new era in insulin therapy. The advent of insulin management systems is set to strengthen the global diabetes therapeutics and diagnostics market.
“Diabetes is a chronic condition that has to be managed with the use of drugs and changes in lifestyle,” notes the analyst of this research. “The quality of diabetes solutions will affect the quality of life for millions of diabetics globally.” The World Diabetes Foundation estimates that there will be 438 million people with diabetes in 2030. Such high-anticipated rates of growth in the diabetic population will be accompanied by continually escalating demand for diabetes solutions.
Effective Offerings, Early Screening and Educational Initiatives to Promote Sustained Market Development
Alarmingly, a large number of diabetics continue to remain undiagnosed. An estimated 50 per cent of the diabetic population is unaware of its condition. This is the biggest hurdle for the insulin delivery device market. Early diagnosis and treatment of diabetes will ensure longer and healthier living for diabetics. It will also sustain long-term revenue growth for manufacturers of insulin delivery devices.
“Appropriate screening and education of the general population to detect and treat diabetes will help market participants garner a larger market share,” advises the analyst. “Products that enhance quality of life will guarantee strong revenue growth and provide the most value to the patient.”
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Diabetes therapeutics
- Diabetes diagnostics
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
